 EDEN PRAIRIE, Minn., Sept. 20, 2022 GLOBE NEWSWIRE -- Miromatrix Medical Inc. NASDAQ: MIRO, a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients lives, today announced CEO Jeff Ross will present at the Bioregate European Regenerative Medicine Forum. The conference, held this year on September 21-23 in Louvain-la-Neuve, Belgium, is dedicated to the 4R Medicine, Repair, Replacement, Regeneration, and Reprogramming. 